5-Bromo-2-Chlorobenzoic Acidum CAS 21739-92-4
Manufacturer Supple, Puritas, Commercial Productio
Dapagliflozin (CAS: 461432-26-8) Intermedia:
5-Bromo-2-Chlorobenzoicum Acidum CAS 21739-92-4
5-Bromo-2-Chloro-4'-Ethoxydiphenylmethane CAS 461432-23-5
2,3,4,6-Tetrakis-O-Trimethylsilyl-D-Gluconolactone CAS 32384-65-9
| Nomen chemicum | 5-Bromo-2-Chlorobenzoicum Acid |
| Synonyma | 2-Chloro-5-Bromobenzoicum Acid |
| CAS Number | 21739-92-4 |
| CATTUS Number | RF-PI439 |
| Stock Status | In Stock, Productio Ascendite ad Tons |
| Formulae hypotheticae | C7H4BrClO2 |
| M. Pondus | 235.46 |
| Liquescens punctum | 154.0 ad 156.0℃ (lit.) |
| Brand | Ruifu Chemical |
| Item | Specifications |
| Aspectus | Off-White ad lux Yellow pulveris |
| Assay | ≥99.0% |
| Aquae (KF) | ≤0.50% |
| Residere in Ignition | ≤0.30% |
| 2-Chlorobenzoicum acidum | ≤0.30% |
| 2-Chloro-3-Bromobenzoicum Acid | ≤0.30% |
| Totalis immunditias | ≤1.0% |
| Test Standard | Enterprise Standard |
| Consuetudinem | Medium Dapagliflozin (CAS: 461432-26-8), typus II diabete |
sarcina: Utrem, aluminium foil, sacculum, 25kg/cardboard Drum, vel secundum exigentiam emptoris.
Repono Condition:Repone in vasis signatis in loco frigido et sicco;A luce et humore protege.
5-Bromo-2-chlorobenzoicum acidum (CAS: 21739-92-4) adhibetur ut principium materiae in synthesi Dapagliflozin (CAS: 461432-26-8), sodium-glucosum selectivum cotransportator-2 inhibitor qui renum minuit. GLYCOSA reabsorptio et aegros cum specie II diabete tractare adhibetur.Dapagliflozin est potens et selectivum SGLT-2(SLC5A2) inhibitor cum EC50 inter 1.1 nM.Permeabilitatem bonam habet per membranas cellulas Caco-2 et subiecta est pro P-glycoproteino (P-gp).Dapagliflozin anno 2012 FDA probatus est.
